0001213900-25-011898.txt : 20250211 0001213900-25-011898.hdr.sgml : 20250211 20250210203301 ACCESSION NUMBER: 0001213900-25-011898 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250211 DATE AS OF CHANGE: 20250210 EFFECTIVENESS DATE: 20250211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lomond Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001900520 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 872959575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-529644 FILM NUMBER: 25607354 BUSINESS ADDRESS: STREET 1: C/O LOMOND THERAPEUTICS HOLDINGS, INC. STREET 2: 8 THE GREEN STE 8490 CITY: DOVER STATE: DE ZIP: 19901 BUSINESS PHONE: 561 464 2841 MAIL ADDRESS: STREET 1: C/O LOMOND THERAPEUTICS HOLDINGS, INC. STREET 2: 8 THE GREEN STE 8490 CITY: DOVER STATE: DE ZIP: 19901 FORMER COMPANY: FORMER CONFORMED NAME: Venetian-1 Acquisition Corp. DATE OF NAME CHANGE: 20211220 D/A 1 primary_doc.xml X0708 D/A LIVE 0001900520 Lomond Therapeutics Holdings, Inc. 8 THE GREEN, SUITE 8490 DOVER DE DELAWARE 19901 212-739-6400 DELAWARE None Venetian-1 Acquisition Corp. Corporation true 2021 Iain Dukes 8 The Green, Suite 8490 Dover DE DELAWARE 19901 Executive Officer Director Nikolay Savchuk 8 The Green, Suite 8490 Dover DE DELAWARE 19901 Executive Officer Director Carl Gordon 8 The Green, Suite 8490 Dover DE DELAWARE 19901 Director Eddie Rodriguez 8 The Green, Suite 8490 Dover DE DELAWARE 19901 Director Pharmaceuticals Decline to Disclose 06b true 0001213900-24-099300 2024-11-01 false true true The initial sale of securities occurred concurrently with the closing of a reverse merger with Lomond Therapeutics OperatingCorporation (f/k/a Lomond Therapeutics, Inc.). The securities were issued to accredited investors. 0 Raymond James & Associates, Inc. 000000705 None None 880 Carillon Parkway St. Petersburg FL FLORIDA 33716 All States false Wedbush & Co., LLC 000328492 None None 600 Montgomery Street, 29th Floor San Francisco CA CALIFORNIA 94111 All States true 63915492 53915492 10000000 Total Amount Sold includes the conversion of SAFEs with an aggregate value of $10,949,992. false 28 3110340 0 In addition to Sales Commissions, warrants to purchase an aggregate of 275,410 shares of the Issuer's Common Stock wereissued to the placement agents. 0 false Lomond Therapeutics Holdings, Inc. /s/ Iain Dukes Iain Dukes Chief Executive Officer 2025-02-10